James Flynn Buys Shares of Lite Strategy, Inc. $LITS
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
James Flynn, insider at Lite Strategy, Inc. ($LITS), bought 25,000 shares at an average price of $0.86, for a total transaction of $21,500. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Lite Strategy, Inc. Stock Down 16.6%
Shares of Lite Strategy, Inc. ($LITS) traded around $0.82 on Friday, down 16.6% for the day.
Lite Strategy, Inc. Earnings
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Get Lite Strategy, Inc. alerts
New 13F filings, insider trades, and analyst moves on $LITS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.